NovoCure Ltd
Total Trades
129
Buys
2
Sells
91
Largest Trade
N/A
Insiders
22
Institutional Funds
185
Inst. Value
$1M+
Activist Filings
21
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| GROENHUYSEN WILHELMUS CM | COO | SELL | $1K–$15K | 294 | $21.82 | Sep 5, 2023 |
| Shah Pritesh | Chief Growth Officer | SELL | $1K–$15K | 273 | $21.82 | Sep 5, 2023 |
| Cordova Ashley | CFO | SELL | $15K–$50K | 1K | $30.25 | Aug 4, 2023 |
| Leonard Frank X | President | SELL | $1M+ | 14K | $75.55 | Mar 7, 2023 |
| Shah Pritesh | Chief Growth Officer | SELL | $1M+ | 21K | $76.16 | Mar 7, 2023 |
| GROENHUYSEN WILHELMUS CM | COO | SELL | $1M+ | 26K | $76.16 | Mar 7, 2023 |
| Cordova Ashley | CFO | SELL | $100K–$500K | 6K | $76.16 | Mar 7, 2023 |
| Burke William Patrick | CHRO | SELL | $15K–$50K | 593 | $76.16 | Mar 7, 2023 |
| Burke William Patrick | CHRO | SELL | $15K–$50K | 281 | $75.28 | Mar 6, 2023 |
| Shah Pritesh | Chief Growth Officer | SELL | $50K–$100K | 937 | $75.28 | Mar 6, 2023 |
| Shah Pritesh | Chief Growth Officer | GRANT | N/A | 47K | — | Mar 6, 2023 |
| GROENHUYSEN WILHELMUS CM | COO | SELL | $50K–$100K | 1K | $75.28 | Mar 6, 2023 |
| GROENHUYSEN WILHELMUS CM | COO | GRANT | N/A | 52K | — | Mar 6, 2023 |
| Cordova Ashley | CFO | SELL | $50K–$100K | 1K | $75.28 | Mar 6, 2023 |
| Cordova Ashley | CFO | GRANT | N/A | 12K | — | Mar 6, 2023 |
| Leonard Frank X | President | GRANT | N/A | 12K | — | Mar 6, 2023 |
| Leonard Frank X | President | SELL | $100K–$500K | 3K | $76.95 | Mar 6, 2023 |
| Leonard Frank X | President | SELL | $100K–$500K | 4K | $75.38 | Mar 3, 2023 |
| Leonard Frank X | President | SELL | $100K–$500K | 2K | $76.36 | Mar 2, 2023 |
| Leonard Frank X | President | GRANT | N/A | 19K | — | Mar 2, 2023 |
| Shah Pritesh | Chief Growth Officer | SELL | $100K–$500K | 2K | $76.36 | Mar 2, 2023 |
| Shah Pritesh | Chief Growth Officer | GRANT | N/A | 19K | — | Mar 2, 2023 |
| Cordova Ashley | CFO | GRANT | N/A | 24K | — | Mar 2, 2023 |
| Cordova Ashley | CFO | SELL | $100K–$500K | 2K | $76.36 | Mar 2, 2023 |
| Burke William Patrick | CHRO | GRANT | N/A | 12K | — | Mar 2, 2023 |
| Burke William Patrick | CHRO | SELL | $50K–$100K | 755 | $76.36 | Mar 2, 2023 |
| GROENHUYSEN WILHELMUS CM | COO | SELL | $100K–$500K | 2K | $76.36 | Mar 2, 2023 |
| GROENHUYSEN WILHELMUS CM | COO | GRANT | N/A | 22K | — | Mar 2, 2023 |
| Weinberg Uri | Chief Science Offi… | SELL | $500K+ | 8K | $116.14 | Jan 9, 2023 |
| Weinberg Uri | Chief Science Offi… | EXERCISE | $50K–$100K | 2K | $47.04 | Jan 9, 2023 |
| Leonard Frank X | President | EXERCISE | $500K+ | 35K | $15.39 | Jan 9, 2023 |
| Leonard Frank X | President | SELL | $1M+ | 40K | $112.25 | Jan 9, 2023 |
| Shah Pritesh | Chief Commercial O… | SELL | $15K–$50K | 387 | $108.00 | Jan 9, 2023 |
| Danziger Asaf | CEO | SELL | $1M+ | 213K | $108.74 | Jan 9, 2023 |
| Danziger Asaf | CEO | EXERCISE | $1M+ | 213K | $7.66 | Jan 9, 2023 |
| Danziger Asaf | CEO | GRANT | $1K–$15K | 39 | $62.30 | Jan 9, 2023 |
| Leonard Frank X | President | SELL | $500K+ | 7K | $76.01 | Oct 17, 2022 |
| Leonard Frank X | President | SELL | $500K+ | 7K | $84.37 | Oct 7, 2022 |
| Leonard Frank X | President | SELL | $500K+ | 7K | $77.35 | Sep 30, 2022 |
| Leonard Frank X | President | SELL | $500K+ | 7K | $77.00 | Sep 26, 2022 |
| Leonard Frank X | Chief Development … | EXERCISE | $15K–$50K | 6K | $7.15 | Sep 19, 2022 |
| Leonard Frank X | Chief Development … | SELL | $1M+ | 12K | $88.52 | Sep 19, 2022 |
| Leonard Frank X | Chief Development … | SELL | $100K–$500K | 2K | $88.00 | Sep 12, 2022 |
| Leonard Frank X | Chief Development … | SELL | $100K–$500K | 1K | $78.57 | Sep 7, 2022 |
| Burke William Patrick | CHRO | SELL | $50K–$100K | 718 | $79.04 | Sep 6, 2022 |
| Cordova Ashley | CFO | SELL | $50K–$100K | 885 | $79.04 | Sep 6, 2022 |
| GROENHUYSEN WILHELMUS CM | COO | SELL | $15K–$50K | 296 | $79.04 | Sep 6, 2022 |
| Shah Pritesh | Chief Commercial O… | SELL | $15K–$50K | 269 | $79.04 | Sep 6, 2022 |
| Leonard Frank X | Chief Development … | SELL | $1M+ | 15K | $77.50 | Sep 6, 2022 |
| Benaim Ely | Chief Medical Offi… | SELL | $100K–$500K | 6K | $73.73 | Aug 4, 2022 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 185 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| Soleus Capital Management, L.P. | 8.5M | $1M+ | SH |
| STATE STREET CORP | 2.6M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 2.1M | $1M+ | SH |
| RENAISSANCE TECHNOLOGIES LLC | 1.4M | $1M+ | SH |
| Palo Alto Investors LP | 1.3M | $1M+ | SH |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1.2M | $1M+ | SH |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 1.0M | $1M+ | SH |
| AMERICAN CENTURY COMPANIES INC | 1.0M | $1M+ | SH |
| C WorldWide Group Holding A/S | 972K | $1M+ | SH |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 927K | $1M+ | SH |
| Point72 Asset Management, L.P. | 900K | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 877K | $1M+ | SH |
| DIMENSIONAL FUND ADVISORS LP | 677K | $1M+ | SH |
| Connor, Clark & Lunn Investment Management Ltd. | 661K | $1M+ | SH |
| BlackRock, Inc. | 543K | $1M+ | SH |
| BAILLIE GIFFORD & CO | 461K | $1M+ | SH |
| BARCLAYS PLC | 444K | $1M+ | SH |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 407K | $1M+ | SH |
| IEQ CAPITAL, LLC | 379K | $1M+ | SH |
| TUDOR INVESTMENT CORP ET AL | 285K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
Soleus Capital Master Fund, L.P.
SC 13G/A · Feb 12, 2026
7.6%
8.5M shares
SC 13G/A · Nov 14, 2025
1.8%
2.0M shares
Soleus Capital Master Fund, L.P.
SC 13G/A · Nov 7, 2025
8.6%
9.6M shares
SC 13G · Aug 13, 2025
5.7%
6.4M shares
Soleus Capital Master Fund, L.P.
SC 13G/A · Aug 5, 2025
6.2%
6.9M shares
Capital International Investors
SC 13G/A · Jul 7, 2025
0.0%
0 shares
SC 13G/A · Apr 24, 2025
8.3%
9.1M shares
Soleus Capital Master Fund, L.P.
SC 13G · Apr 1, 2025
5.0%
5.5M shares
The Vanguard Group - 23-1945930
SC 13G/A · Jul 10, 2024
10.3%
11.1M shares
The Vanguard Group - 23-1945930
SC 13G/A · Feb 13, 2024
9.1%
9.8M shares
Capital World Investors 95-1411037
SC 13G/A · Feb 9, 2024
3.1%
3.3M shares
Capital International Investors 95-1411037
SC 13G/A · Feb 9, 2024
8.3%
8.9M shares
Capital World Investors 95-1411037
SC 13G/A · Dec 11, 2023
5.5%
5.8M shares
Baillie Gifford & Co (Scottish partnership)
SC 13G/A · Nov 9, 2023
4.8%
5.1M shares
Capital International Investors 95-1411037
SC 13G/A · Feb 13, 2023
7.8%
8.2M shares
Capital World Investors 95-1411037
SC 13G/A · Feb 13, 2023
12.3%
12.9M shares
Baillie Gifford & Co (Scottish partnership)
SC 13G/A · Jan 23, 2023
8.4%
8.9M shares
SC 13G/A · Apr 11, 2022
10.3%
10.7M shares
Capital World Investors 95-1411037
SC 13G/A · Feb 11, 2022
12.3%
12.7M shares
Capital International Investors 95-1411037
SC 13G/A · Feb 11, 2022
11.1%
11.5M shares
Baillie Gifford & Co (Scottish partnership)
SC 13G/A · Jan 26, 2022
9.3%
9.6M shares